Journal
TRENDS IN BIOTECHNOLOGY
Volume 35, Issue 7, Pages 625-639Publisher
ELSEVIER SCIENCE LONDON
DOI: 10.1016/j.tibtech.2017.04.002
Keywords
-
Categories
Funding
- Howard Hughes Medical Institute
- Gordon and Betty Moore Foundation
Ask authors/readers for more resources
Recent advances in optogenetics have opened new routes to drug discovery, particularly in neuroscience. Physiological cellular assays probe functional phenotypes that connect genomic data to patient health. Optogenetic tools, in particular tools for all-optical electrophysiology, now provide a means to probe cellular disease models with unprecedented throughput and information content. These techniques promise to identify functional phenotypes associated with disease states and to identify compounds that improve cellular function regardless of whether the compound acts directly on a target or through a bypass mechanism. This review discusses opportunities and unresolved challenges in applying optogenetic techniques throughout the discovery pipeline- from target identification and validation, to target-based and phenotypic screens, to clinical trials.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available